Lithium-induced nephrotic syndrome in a young pediatric patient.
Lithium-induced nephrotic syndrome is a rare complication of lithium therapy and is even rarer in children. Most reported cases have been secondary to minimal change disease, which reverses within 1-4 weeks on discontinuation of lithium therapy. However, focal glomerulosclerosis (FSGS) has occasionally been reported and is not always reversible with discontinuation of lithium. We report an 11-year-old child with lithium-induced FSGS nephrotic syndrome who went into full remission after lithium was discontinued.
Sakarcan
Abdullah
A
8 Medical Park, Department of Pediatrics, Division of Pediatric Nephrology, Columbia, SC 29203, USA. abdullahsakarcan@hotmail.com
Thomas
David B
DB
O'Reilly
Kevin P
KP
Richards
Robert W
RW
D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D002648:Child; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced*
D018692:Antimanic Agents